Robert Cyril Bollinger

Professor
Medicine - Infectious Diseases
Johns Hopkins University
United States of America

Biography

Dr. Robert C. Bollinger is a professor of medicine at the Johns Hopkins University School of Medicine. He holds joint appointments in the Department of International Health at the Bloomberg School of Public Health and in the School of Nursing’s Department of Community-Public Health. Dr. Bollinger has more than 35 years of experience in international public health, clinical research and education dealing with such global health priorities as HIV/AIDS, malaria, tuberculosis, leprosy, dengue, antibiotic-resistant infections and other emerging diseases. He is the founding director of the Johns Hopkins Center for Clinical Global Health Education (CCGHE) and the associate director for medicine of the Center for Global Health. He also serves as director of both the Johns Hopkins Fogarty India Program—a component of the NIH Fogarty International Center—and the IMEC-JHU Partnership to advance applications in health care. Under Dr. Bollinger’s leadership of the Fogarty India Program, short-term and degree training has been provided to more than 100 visiting scientists at Johns Hopkins, and in-country training has been provided to more than 2,000 Indian scientists. His commitment to clinician education has been honored with the Johns Hopkins Department of Medicine David M. Levine Excellence in Mentoring Award. Dr. Bollinger’s research interests include identifying biological and behavioral risk factors for HIV transmission; characterizing the clinical progression and treatment of HIV and related infections; and implementing science research projects to optimize healthcare capacity and delivery in resource-limited settings. Dr. Bollinger is author of more than 150 peer-reviewed research publications and 15 book chapters, including the first and largest studies of risk factors for HIV transmission in India, the cloning and sequencing of the first HIV viruses from India, the only studies characterizing the primary immune response to HIV in India, and the demonstration of increased risk of HIV acquisition with recent HSV infection and lack of circumcision. He has been invited to participate in public health training programs and expert committees, and has been consulted for his expertise by more than 15 countries. Dr. Bollinger has served as a member of the US Presidential Advisory Council for HIV/AIDS (PACHA) and as a member of the PACHA International Subcommittee, and is a current member of the Institute of Medicine Forum on Public-Private Partnerships for Global Health and Safety. Working with partners in more than 20 countries, Dr. Bollinger and CCGHE faculty pioneered the development and use of distance learning and their award-winning mobile health platform emocha® in resource-limited settings. Dr. Bollinger received an undergraduate degree from Haverford College, an M.D. from Dartmouth Medical School and an M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He completed his internal medicine training at the University of Maryland Medical Systems, followed by a post-doctoral fellowship in infectious diseases at Johns Hopkins. He is board certified by the American Board of Internal Medicine in internal medicine and infectious diseases.

Research Intrest

Global health workforce education and capacity building; Public health; International health; Human immunodeficiency virus (HIV); Tuberculosis; Tropical medicine; Mobile health; Point-of-care diagnostics; India; Ethiopia; Zambia; Uganda; South Africa

List of Publications
Sahay S, Deshpande S, Bembalkar S, Kharat M, Parkhe A, Brahme RG, Paranjape R, Bollinger RC, Mehendale SM. "Failure to use and sustain male condom usage: lessons learned from a prospective study among men attending STI clinic in Pune, India." PLoS One. 2015 Aug 13;10(8):e0135071.
Chang LW, Nakigozi G, Billioux VG, Gray RH, Serwadda D, Quinn TC, Wawer MJ, Bollinger RC, Reynolds SJ. "Effectiveness of peer support on care engagement and preventive care intervention utilization among pre-antiretroviral therapy, HIV-infected adults in Rakai, Uganda: A randomized trial." AIDS Behav. 2015 Oct;19(10):1742-51.
Shivakoti R, Gupta A, Ray JC, Uprety P, Gupte N, Bhosale R, Mave V, Patil S, Balasubramanian U, Kinikar A, Bharadwaj R, Bollinger RC, Persaud D. "Soluble CD14: an independent biomarker for risk of HIV mother-to-child transmission in setting of pre- and post-exposure antiretroviral prophylaxis." J Infect Dis. 2015 Oct 6.